Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 3 Results of logistic regression for site of first (s) and subsequent of recurrence

From: Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study

  Univariate analysis
OR (95% CI)
P-value Multivariate analysis
OR (95% CI)
P-value
  HR-negative vs. positive   HR-negative vs. positive  
Local regional
vs.
Distant
0.71 (0.44,1.15) 0.162 0.74 (0.44, 1.23) 0.246
Brain vs. Other 1.37 (0.93, 2.02) 0.107 1.31 (0.88, 1.95) 0.191
Bone vs. Other 0.54 (0.37, 0.78) 0.001 0.55 (0.37, 0.80) 0.002
Lung vs. Other 1.48 (1.00, 2.18) 0.050 1.45 (0.98, 2.15) 0.061
Liver vs. Other 1.01 (0.69, 1.48) 0.954 1.06 (0.72, 1.56) 0.764
  1. Note: HR, Hormone receptor. Adjusting by age at diagnosis, stage and adjuvant trastuzumab.